北大医药
(000788)
| 流通市值：32.06亿 | | | 总市值：32.06亿 |
| 流通股本：5.96亿 | | | 总股本：5.96亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 447,110,790.57 | 215,174,005.41 | 1,482,371,745.21 | 1,231,193,296.53 |
| 营业总成本 | 376,536,216.85 | 187,513,185.93 | 1,324,838,103.56 | 1,079,788,503.83 |
| 其他经营收益 | | | | |
| 营业利润 | 66,820,612.43 | 31,254,803.73 | 141,862,998.64 | 164,037,852.21 |
| 利润总额 | 67,100,461.68 | 31,310,786.84 | 102,666,136.51 | 166,655,663.05 |
| 净利润 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 | 135,980,653.15 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 55,670,813.75 | 26,996,289.91 | 82,882,957.79 | 135,980,653.15 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,543,845,608.01 | 1,475,882,963.05 | 1,662,474,867.6 | 1,756,179,177.74 |
| 非流动资产: | | | | |
| 非流动资产合计 | 379,050,015.15 | 409,878,970.38 | 330,341,017.86 | 342,710,784.38 |
| 资产总计 | 1,922,895,623.16 | 1,885,761,933.43 | 1,992,815,885.46 | 2,098,889,962.12 |
| 流动负债: | | | | |
| 流动负债合计 | 324,771,773.54 | 313,542,055.47 | 368,635,176.19 | 462,867,928.46 |
| 非流动负债: | | | | |
| 非流动负债合计 | 81,346,511.42 | 84,117,063.6 | 62,948,297.42 | 21,691,926.45 |
| 负债合计 | 406,118,284.96 | 397,659,119.07 | 431,583,473.61 | 484,559,854.91 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,517,423,721.32 | 1,488,749,197.48 | 1,561,878,794.97 | 1,614,976,490.33 |
| 股东权益合计 | 1,516,777,338.2 | 1,488,102,814.36 | 1,561,232,411.85 | 1,614,330,107.21 |
| 负债和股东权益合计 | 1,922,895,623.16 | 1,885,761,933.43 | 1,992,815,885.46 | 2,098,889,962.12 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 704,569,547.34 | 456,784,839.29 | 2,128,682,342.91 | 1,541,643,128.31 |
| 经营活动现金流出小计 | 462,215,589.02 | 269,331,224.65 | 1,741,390,785.62 | 1,409,904,772.09 |
| 经营活动产生的现金流量净额 | 242,353,958.32 | 187,453,614.64 | 387,291,557.29 | 131,738,356.22 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 165,445,022.55 | 92,801,474.61 | 96,017,992.4 | 57,391,730.98 |
| 投资活动现金流出小计 | 381,845,092.23 | 136,894,689.86 | 444,159,326.22 | 107,799,132.46 |
| 投资活动产生的现金流量净额 | -216,400,069.68 | -44,093,215.25 | -348,141,333.82 | -50,407,401.48 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 5,942,460.44 | - |
| 筹资活动现金流出小计 | 117,412,305.36 | 115,074,141.85 | 86,384,663.23 | 45,682,824.27 |
| 筹资活动产生的现金流量净额 | -117,412,305.36 | -115,074,141.85 | -80,442,202.79 | -45,682,824.27 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -91,458,416.72 | 28,286,257.54 | -41,291,979.32 | 35,648,130.47 |
| 期末现金及现金等价物余额 | 453,680,273.62 | 573,424,947.88 | 545,138,690.34 | 622,078,800.13 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -91,458,416.72 | - | -41,291,979.32 | - |